Target intelligence / Profile preview

Protein transport protein Sec61 subunit alpha (SEC61A1)

Target
SEC61A1
Molecular classification
Transporter, Ion channel, Receptor
01

Overview

Protein transport protein Sec61 subunit alpha (Sec61α) is the primary pore-forming subunit of the heterotrimeric Sec61 translocon complex, which is essential for protein biogenesis in the endoplasmic reticulum (ER) [1, 3]. It facilitates the translocation of nascent polypeptides into the ER lumen and the integration of transmembrane proteins into the lipid bilayer, a process critical for roughly one-third of the human proteome [15, 16]. In addition to its transport function, Sec61α acts as a passive calcium leak channel and a ribosome receptor, playing a key role in maintaining cellular calcium homeostasis and regulating the unfolded protein response [4, 6]. Genetic mutations in SEC61A1 lead to "Sec61-channelopathies," manifesting as kidney disease, neutropenia, or immunodeficiency [1, 12]. Pharmacologically, Sec61α is an emerging target for cancer therapy; small-molecule inhibitors like KZR-261 can selectively block the translocation of specific "client" proteins, such as oncogenic growth factors, thereby inducing ER stress and cell death [6, 8]. Furthermore, Sec61α inhibitors exhibit potent antiviral properties by disrupting the production of viral envelope glycoproteins required for the assembly of viruses like SARS-CoV-2 and Ebola [4, 7].

Other names
SEC61A1HSEC61SEC61ASec61 alpha 1Sec61 translocon alpha 1 subunitHNFJ4ADTKD5Protein transport protein Sec61 subunit alpha isoform 1
02

Mechanism of action

Inhibition of protein translocation into the endoplasmic reticulum by stabilizing the translocon in a closed state or blocking signal peptide recognition, leading to ER stress and apoptosis.

03

Biological functions

Protein translocationMembrane protein insertionCalcium homeostasisRibosome bindingSignal peptide recognitionUnfolded protein response regulation
04

Disease associations

CancerInfectionImmunodeficiencyKidney diseaseDiabetesInflammation
05

Safety considerations

Broad cytotoxicityER stress inductionCalcium dysregulationSystemic toxicityImmunosuppression
06

Interacting drugs

KZR-261

7 more in the full profile.

07

Biomarkers

SEC61A1 mutationsCHOP expressionBiP levelsCD4 surface expression

Beyond the preview

Go deeper on Protein transport protein Sec61 subunit alpha (SEC61A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein transport protein Sec61 subunit alpha (SEC61A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call